Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial. Sellars MC, Frank JA, Shim B, Vanasse A, et al. Nat Med 2026 Oct 14. doi: 10.1038/s41591-026-04717.

Read + Share

Amedeo Smart

Independent Medical Education

Sellars MC, Frank JA, Shim B, Vanasse A, et al. Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial. Nat Med 2026 Oct 14. doi: 10.1038/s41591-026-04717.
PMID: 42875558